Skip to main content
Fig. 1 | BMC Bioinformatics

Fig. 1

From: DeepAEG: a model for predicting cancer drug response based on data enhancement and edge-collaborative update strategies

Fig. 1

The framework of DeepAEG. DeepAEG mainly includes three parts: data enhancement, drug feature mining and gene expression feature extraction. The drug feature mining module is divided into CGCN module and transformer module. SMILES expression of cancer drugs is data-enhanced after input and converted into advanced latent characterization by the Encoder and Transformer sections of the GCNC, respectively. The features of cancer cell profiles extracted by the sub-networks are connected and input into the classifier network

Back to article page